ENTITY
Celltrion Inc

Celltrion Inc (068270 KS)

476
Analysis
Health CareSouth Korea
Celltrion Inc. produces and sells biosimilar products and also provides consignm ent processing service for other companies. The Company's main product is Abata cept which is for arthritis treatment
more
Refresh
13 Aug 2019 10:30

KOSPI Short Interest and a Trading Strategy

The Korea Exchange (KRX) publishes outstanding short position data daily with a two day lag.Current short notional on the KOSPI market is KRW...

Logo
445 Views
Share
bullishCelltrion Inc
20 Jun 2019 13:22

Celltrion Bullish off of Cycle Low with Base Risk Tactics

Celltrion Inc (068270 KS) ​has performed well from our long call at 180k Celltrion Cycle Low Synergies ​on April 30, 2019. The tactical short from...

Share
21 May 2019 09:07

Celltrion H Block Deals Priced at Floor: More Short Entry Points Should Be On the Way

This block deal was another nice exit point for Celltrion H short sellers to wrap up short position. Just, 6.5M offering was simply massive, and...

Logo
591 Views
Share
20 May 2019 21:29

One Equity Partners Plans to Sell 4.5% Stake of Celltrion Healthcare

It was announced after market close today that One Equity Partners plans to sell 6.5 million shares (4.5% of shares outstanding) of Celltrion...

Logo
563 Views
Share
13 May 2019 17:58

Smartkarma’s Week that Was in JP/​​​​​​​KR: Chiyoda, SoftBank, Nexon and CJ Olive Networks

We have covered two weeks of insights in this week’s report as we did not publish the weekly during the first week of May as Japan was enjoying an...

Share
x